Status: Recruiting
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
To compare the efficacy and safety of subsegmental treatment and segmental treatment with InterVapor in patients with severe emphysema
Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Chest HospitalUpdated: Sep 8, 2025Locations: 9
Eligibility criteria
Age≥18 years old; [+7]
Concomitant illnesses or medications that would pose a significant increased ris... [+11]